Interview with Zbigniew Pawlowski, president of the Association of Families of Patients with Amyloidosis.
In an audit conducted earlier this year, representatives of patients with transthyretin amyloidosis once again highlighted an urgent and unfortunately still unmet need. This is access to causal treatment, so that patients could be managed in accordance with international guidelines. What is the situation for these patients now?
Invariably... It's been four years since the...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
